Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06288672 · ClinicalTrials.gov registry record · NA

IBS Skin Patch Test Food Allergy Study

A NA study of Irritable Bowel Syndrome, sponsored by IBS-80.

Recruiting
Registry status
NA
Development phase
250
Enrollment target
2
Study locations

NCT06288672: Recruiting NA study of Irritable Bowel Syndrome, sponsored by IBS-80.

NCT06288672 is a NA study of Irritable Bowel Syndrome that is actively recruiting participants, run by IBS-80. The registered enrollment target is 250 participants, above the 139-participant average among 47 other Irritable Bowel Syndrome trials with a reported enrollment target (80% higher). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06288672, a NA study of Irritable Bowel Syndrome, is actively recruiting participants, sponsored by IBS-80.

RECRUITING
Registry status
NA
Development phase
250 participants
Enrollment target
2
Study locations

Study Summary

Participants with IBS are skin patch tested (no needles) to 80 different foods and food additives, compounded for patch testing, in search of food allergies. The testing requires 3 office visits within a 4 or 5 day period. The patches are taped to the back at Visit #. At Visit #2 48 hours later, the patches are removed from the skin and the outside border of each patch is marked with a felt tip marker. At Visit #3 (final visit) 1 or 2 days later, the patch test reading is performed by the doctor-investigator. An allergy is identified as a small red mark where the food was in contact with the skin for 48 hours. Those participants found to have food allergies are then placed on an avoidance diet (no calorie restriction) for 16 weeks where they either avoid eating the food(s) to which they are allergic (the \"true\" avoidance diet) or food(s) to which the testing did not show an allergy (this is called the \"sham\" avoidance diet). There is a 50/50 chance of going on either avoidance diet. The avoidance diet is assigned in such a way that neither the participant or the doctor-investigator knows which diet is being followed. After the 16 weeks, the participants answers a brief online questionnaire that asks about the IBS symptoms while following the avoidance diet. After the 16 week avoidance diet and final questionnaire are completed, those participants who were on the sham diet will be told of their true food allergies which they may try avoiding on their own.

Primary Outcome

Participant global assessment of IBS symptoms compared to the three months prior to entering study, assessed by a post-avoidance diet questionnaire. The assessment is a 7 point Likert scale with 1=substantially improved; 2=moderately improved; 3=slightly improved; 4=no change; 5=slightly worse; 6=moderately worse; 7=substantially worse

Conditions Studied

Interventions

  • OTHER True avoidance diet
  • OTHER Sham avoidance diet

Study Locations (2)

Pennsylvania

  • North Wales Dermatology, PLLC - North Wales

West Virginia

  • Shepherd Allergy - Barboursville

Trial Details

FieldValue
Enrollment Target 250 participants
Start Date 2023-08-15
Est. Completion 2026-12
Phase NA
IBS-80

1 total trials

What NCT06288672 shows while recruiting

NCT06288672 is an interventional study that assigns participants to a tested intervention. The registered 250 participants enrollment target is mid-sized for trials with a published cap, above the 139-participant average among 47 other Irritable Bowel Syndrome trials with a reported enrollment target (80% higher).

The record links to 1 condition, with Irritable Bowel Syndrome appearing as the primary indexed condition, and to 2 interventions - of which True avoidance diet is the first listed.

NCT06288672 reports a single indexed study location in Pennsylvania, West Virginia.

Frequently Asked Questions

What is clinical trial NCT06288672 about?

NCT06288672 is a clinical study titled "IBS Skin Patch Test Food Allergy Study". Participants with IBS are skin patch tested (no needles) to 80 different foods and food additives, compounded for patch testing, in search of food allergies. The testing requires 3 office visits within a 4 or 5 day period. The patches are taped to the back at Visit #. At Visit #2 48 hours later, the...

What is the current status of trial NCT06288672?

This trial is currently recruiting. It is a NA study. The enrollment target is 250 participants. The study started on 2023-08-15. Estimated completion is 2026-12.

What conditions does trial NCT06288672 study?

This clinical trial studies the following conditions: Irritable Bowel Syndrome.

What interventions are being tested in trial NCT06288672?

The interventions under investigation include: True avoidance diet (OTHER), Sham avoidance diet (OTHER).

Who is sponsoring clinical trial NCT06288672?

This trial is sponsored by IBS-80, which has 1 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06288672 being conducted?

This trial has 2 study locations across Pennsylvania, West Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Irritable Bowel Syndrome

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06288672's enrollment target sits among peer trials

250 9th of 47 higher than 38 of 47 other Irritable Bowel Syndrome trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Irritable Bowel Syndrome trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00483249 · 250 participants · NA

    Endovascular Exclusion of Thoracoabdominal and/or Paravisceral Abdominal Aortic Aneurysm

  • NCT00777712 · 250 participants

    Mechanisms Underlying Impaired Diabetic Wound Healing

  • NCT01451502 · 250 participants · NA

    Infusion of Cell Populations From Unlicensed Umbilical Cord Blood Units

  • NCT01771718 · 250 participants

    Pilot Study on In-vivo Non-invasive Skin Imaging Using Multiphoton Microscopy

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06288672, the US trial registry maintained by the National Library of Medicine. NCT06288672 (mid enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.